NCT05450016 Assessment of the Breast Cosmesis Using Deep Neural Networks: an Exploratory Study (ABCD)
| NCT ID | NCT05450016 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tata Memorial Centre |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 720 participants |
| Start Date | 2021-10-04 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 720 participants in total. It began in 2021-10-04 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Surgery and radiotherapy in breast cancer patients can cause treatment changes and may affect the final breast appearance. In this study, we are trying to evaluate the post treatment breast photographs of the patients and subject these to Artificial Intelligence based program so as to classify into appropriate categories based upon changes from baseline. This automated solution will help in decreasing the time required to achieve this task by physicians in the clinic.
Eligibility Criteria
Inclusion Criteria: * Confirmed diagnosis of primary breast cancer (invasive or in situ) * Patient undergone breast conservation / Whole breast reconstruction * Patient received breast RT * Already provided written informed consent on earlier projects * Patient provided photographs of both breasts * Non-metastatic disease or oligometastatic * Age \> 18 years * Reconsent given Exclusion Criteria: * Mastectomy without whole breast reconstruction * Bilateral breast cancer * Partial breast irradiation * Male patient * Limited life expectancy due to co-morbidity * Patients undergoing brachy boost
Contact & Investigator
Tabassum Wadasadwala, MD
PRINCIPAL INVESTIGATOR
Tata Memorial Centre
Frequently Asked Questions
Who can join the NCT05450016 clinical trial?
This trial is open to female participants only, aged 19 Years or older, up to 80 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05450016 currently recruiting?
Yes, NCT05450016 is actively recruiting participants. Contact the research team at twadasadwala@actrec.gov.in for enrollment information.
Where is the NCT05450016 trial being conducted?
This trial is being conducted at Mumbai, India.
Who is sponsoring the NCT05450016 clinical trial?
NCT05450016 is sponsored by Tata Memorial Centre. The principal investigator is Tabassum Wadasadwala, MD at Tata Memorial Centre. The trial plans to enroll 720 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.